Literature DB >> 31338431

Neurodevelopmental delay in normocephalic children with in utero exposure to Zika virus.

Angelina Xavier Acosta1, Isadora Cristina de Siqueira2, Adriana Virginia Faiçal1, Juliana Cabral de Oliveira2, João Vitor Vieira Oliveira2, Breno Lima de Almeida2, Iluska Andrade Agra1, Luiz Carlos Junior Alcantara2.   

Abstract

Neurodevelopment in 29 normocephalic children with in utero exposure to Zika virus (ZIKV) was evaluated by the Bayley Scales of Infant and Toddler Development-Third Edition. Ten (35%) infants presented neurodevelopment delay. Language, cognitive and motor delays were identified in 9 (31%), 4 (14%) and 1 (3%) infants, respectively. Children exposed to ZIKV in utero must undergo careful evaluations for the early detection of any neurodevelopment delays in order to implement prompt intervention.

Entities:  

Keywords:  Bayley-III; Zika virus; congenital infection; neurodevelopment

Year:  2019        PMID: 31338431      PMCID: PMC6613842          DOI: 10.1136/bmjpo-2019-000486

Source DB:  PubMed          Journal:  BMJ Paediatr Open        ISSN: 2399-9772


Introduction

Congenital Zika infection (CZI) was identified as a devastating consequence of Zika virus (ZIKV) infection during pregnancy.1 The clinical presentation of CZI is variable, including microcephaly, sensorineural hearing loss, visual impairment and arthrogryposis.2 Moreover, a broad clinical spectrum of outcomes, including minor disorders, have also been identified.3 Furthermore, late-onset microcephaly was reported in infants with confirmed CZI and normocephaly at birth4

Methods

The present study aimed to investigate the neurodevelopment of non-microcephalic infants with intrauterine exposure to ZIKV who were born in Salvador, located in north-eastern Brazil, in an effort to contribute to the understanding of the broad spectrum of manifestations associated with this congenital infection. Normocephalic infants were recruited from a previous CZI hospital surveillance programme,5 if their serological testing or a quantitative PCR assay (RT-qPCR) for ZIKV was positive. Six (20%) of the newborns had ZIKV positivity by RT-qPCR and the others by serology. All their mothers had anti-ZIKV IgG positivity at the time of delivery. All infants were born during the 2016 ZIKV outbreak, and all mothers reported ZIKV infection symptoms during pregnancy. Newborns were considered normocephalic if head circumference (HC) at birth measured within 2 SD for gestational age and sex, according to the INTERGROWTH-21 standards.6 Development was assessed using the Bayley Scales of Infant and Toddler Development-Third Edition (BSID-III), which was previously validated for the Brazilian population.7 An adjustment to the age at the time of testing was made to evaluate infants with prematurity. According to the BSID-III, deviations in an individual’s composite score from the normative mean (100±15) are used to classify neurodevelopment as normal: within 1 SD of the mean (≥85); mild: –1 to –2 SD (≥70 and <85); moderate: –2 to –3 SD (≥55 and <70); or severe: more than 3 SD below the standard mean scores (<55). Complementary evaluations included retinal mapping, refraction evaluation and the assessment of brainstem auditory evoked response. No neuroimaging was performed.

Patient and public involvement

The present study did not include patient or public involvement.

Results

Thirty-one infants were enrolled and 29 infants were evaluated, as two were excluded due to hydrocephalus or genetic disorders. Of the total evaluated, 16 (55%) were male with a mean age of 18.2±3.8 months. All maternal and newborn sociodemographic data are presented in table 1.
Table 1

Sociodemographic and clinical data of 29 children evaluated by the BSID-III, Salvador, Brazil

n (%)
Mothers
 Mother’s age (years)*25±6.4
 Maternal schooling
 Elementary8 (27.6)
 Secondary20 (69.0)
 University1 (3.4)
Marital status
 Married8 (27.6)
 Single21 (72.4)
 Household income (minimum monthly wage)
 <113 (44.8)
 1–314 (48.3)
 >32 (6.9)
Infants
 Gestational age at birth* (weeks)38.4±2.1
 Prematurity5 (17.2)
 Birth weight (g)*3060±573.5
 Head circumference at birth (cm)*33.5±1.8
 Mean age at time of BSID evaluation (months)*18.2±3,8
 Male gender16 (55.2)

*Mean±SD; minimum monthly wage=$R954 (US$~240).

BSID-III, Bayley Scales of Infant and Toddler Development-Third Edition.

Sociodemographic and clinical data of 29 children evaluated by the BSID-III, Salvador, Brazil *Mean±SD; minimum monthly wage=$R954 (US$~240). BSID-III, Bayley Scales of Infant and Toddler Development-Third Edition. Developmental assessment showed that 10 (34%) of the infants exhibited a delay in at least one of the BSID-III scale domains. Language delay was identified in 9 (31%) infants, cognitive delay in 4 (14%) and motor delay in 1 (3%) child (table 2).
Table 2

Neurodevelopmental evaluations of 29 children with intrauterine exposure to ZIKV using the Bayley Scales of Infant and Toddler Development-Third Edition (BSID-III), Salvador, Bahia, 2018

Categorisation of developmental delay, n (%)
BSID-III domainMean score (SD)RangeSevere (score <55)−3 SDModerate (score 55–69)−2 SD/−3 SDMild (score 70–84)−1 SD/−2 SDNone (score ≥85)1 SD
Cognitive102.2±16.970–145004 (13.8%)25 (86.6%)
Language93.8±18.547–1351 (3.4%)1 (3.4%)7 (24.1%)20 (69.1%)
Motor103.5±12.079–127001 (3.4%)28 (96.6%)

BSID-III, Bayley Scales of Infant and Toddler Development-Third Edition; ZIKV, Zika virus.

Neurodevelopmental evaluations of 29 children with intrauterine exposure to ZIKV using the Bayley Scales of Infant and Toddler Development-Third Edition (BSID-III), Salvador, Bahia, 2018 BSID-III, Bayley Scales of Infant and Toddler Development-Third Edition; ZIKV, Zika virus. Regarding the nine infants who exhibited language impairment, one presented a severe delay, one had moderate delay and seven were classified as having mild delay. When analysing their respective scaled scores, 2 (22%) infants demonstrated an expressive ability below average. Audiological evaluations were performed in 16 (55%) infants, who showed normal auditory conduction, including five of the infants with language delay. Ophthalmological evaluations were performed in 23 (79%) infants, with no abnormalities identified. All HC were found to be within the normal range in accordance with age and gender.

Discussion

In this study, 10 (34%) normocephalic infants presented some type of neurodevelopmental delay. These findings corroborate results reported by a prospective cohort study in Rio de Janeiro that evaluated children by neuroimaging and the BSID-III, in which neurodevelopment delays were observed in the cognitive, language and motor function domains.8 Language function was found to be the most impaired domain among the children evaluated. Verbal abilities are known to be more sensitive to myelination in typical children, and children with language delays are reported to be at greater risk for below-average academic, social and emotional development, thereby compromising quality of life.9 This study suffers from some limitations, as the present design prevented us from establishing any causal relationships between exposure to ZIKV and developmental delay. In conclusion, our evaluations identified abnormalities in neurodevelopmental outcome, especially language functioning, which should be confirmed by larger scale studies involving prospective cohorts and long-term follow-up. The systematic assessment of these children, through standardised tools, is crucial for the early detection of abnormal development, as well as to provide intervention to achieve best outcomes and prevent disabilities.
  12 in total

Review 1.  Neurodevelopment in Normocephalic Children Exposed to Zika Virus in Utero with No Observable Defects at Birth: A Systematic Review with Meta-Analysis.

Authors:  Elena Marbán-Castro; Laia J Vazquez Guillamet; Percy Efrain Pantoja; Aina Casellas; Lauren Maxwell; Sarah B Mulkey; Clara Menéndez; Azucena Bardají
Journal:  Int J Environ Res Public Health       Date:  2022-06-14       Impact factor: 4.614

2.  Neurodevelopmental Abnormalities Associated With In Utero Zika Virus Infection in Infants and Children-The Unfolding Story.

Authors:  Margaret A Honein; Kate R Woodworth; Christopher J Gregory
Journal:  JAMA Pediatr       Date:  2020-03-01       Impact factor: 16.193

3.  A prospective study of neurodevelopmental trends between 3 and 24 months in normocephalic infants with prenatal Zika virus exposure: Evidence of emerging communication delays in the NATZIG cohort.

Authors:  Alexandra P Key; Silvia F B de Moura Negrini; Carla A C Tanuri Caldas; Sara Reis Teixeira; Adriana R T Anastasio; Juliana Cavalcante; Marisa M Mussi-Pinhata; Linda J Hood
Journal:  Early Hum Dev       Date:  2021-09-15       Impact factor: 2.079

4.  Language delay was associated with a smaller head circumference at birth in asymptomatic infants prenatally exposed to the Zika virus.

Authors:  Laura Medeiros Andrade; Maria Dalva Baker Meio; Saint Clair Gomes; Juliana Paiva Souza; Mirza R Figueiredo; Roozemeria Pereira Costa; Patricia Brasil; Karin Nielsen-Saines; Elizabeth Brickley; Maria Elisabeth Lopes Moreira
Journal:  Acta Paediatr       Date:  2021-05-03       Impact factor: 4.056

5.  Neurological Findings in Children without Congenital Microcephaly Exposed to Zika Virus in Utero: A Case Series Study.

Authors:  Marília Rosa Abtibol-Bernardino; Lucíola de Fátima Albuquerque de Almeida Peixoto; Geruza Alfaia de Oliveira; Tatiane Freitas de Almeida; Gabriela Ribeiro Ivo Rodrigues; Rodrigo Haruo Otani; Beatriz Caroline Soares Chaves; Cristina de Souza Rodrigues; Anny Beatriz Costa Antony de Andrade; Elijane de Fatima Redivo; Salete Sara Fernandes; Marcia da Costa Castilho; Silvana Gomes Benzecry; Camila Bôtto-Menezes; Flor Ernestina Martinez-Espinosa; Maria das Graças Costa Alecrim
Journal:  Viruses       Date:  2020-11-20       Impact factor: 5.048

6.  Neurodevelopmental Outcomes of Children Following In Utero Exposure to Zika in Nicaragua.

Authors:  Elizabeth M Stringer; Evelin Martinez; Bryan Blette; Christian Eduardo Toval Ruiz; Michael Boivin; Omar Zepeda; Jeffrey S A Stringer; Marlen Morales; Shiara Ortiz-Pujols; Itziar Familiar; Matthew Collins; Meylin Chavarria; Barbara Goldman; Natalie Bowman; Aravinda de Silva; Daniel Westreich; Michael Hudgens; Sylvia Becker-Dreps; Filemon Bucardo
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

7.  Improving neurodevelopment in Zika-exposed children: A randomized controlled trial.

Authors:  Randall Waechter; Kemi S Burgen; Bianca Punch; Roberta Evans; Karen Blackmon; Trevor Noël; Michelle Fernandes; Barbara Landon
Journal:  PLoS Negl Trop Dis       Date:  2022-03-08

Review 8.  Neurodevelopment in Children Exposed to Zika in utero: Clinical and Molecular Aspects.

Authors:  Lavínia Schuler-Faccini; Miguel Del Campo; Alfredo García-Alix; Liana O Ventura; Juliano André Boquett; Vanessa van der Linden; André Pessoa; Hélio van der Linden Júnior; Camila V Ventura; Mariana Carvalho Leal; Thayne Woycinck Kowalski; Lais Rodrigues Gerzson; Carla Skilhan de Almeida; Lucélia Santi; Walter O Beys-da-Silva; André Quincozes-Santos; Jorge A Guimarães; Patricia P Garcez; Julia do Amaral Gomes; Fernanda Sales Luiz Vianna; André Anjos da Silva; Lucas Rosa Fraga; Maria Teresa Vieira Sanseverino; Alysson R Muotri; Rafael Lopes da Rosa; Alberto Mantovani Abeche; Clairton Marcolongo-Pereira; Diogo O Souza
Journal:  Front Genet       Date:  2022-03-08       Impact factor: 4.599

9.  Neurodevelopment in normocephalic children with and without prenatal Zika virus exposure.

Authors:  Karen Blackmon; Roberta Evans; Michelle Fernandes; Barbara Landon; Trevor Noel; Calum Macpherson; Nikita Cudjoe; Kemi S Burgen; Bianca Punch; Amy Krystosik; Elysse N Grossi-Soyster; Angelle Desiree LaBeaud; Randall Waechter
Journal:  Arch Dis Child       Date:  2021-09-03       Impact factor: 3.791

10.  Health surveillance and development of children with congenital Zika Virus syndrome: an integrative literature review.

Authors:  Fernanda de Brito Matiello; Jeniffer Stephanie Marques Hilário; Ellen Cristina Gondim; Darci Neves Santos; Débora Falleiros de Mello
Journal:  Rev Paul Pediatr       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.